Results 131 to 140 of about 3,481,061 (289)
Zinc transporter SLC39A14 sustains intracellular Zn2+ levels to activate SIRT3‑dependent ANXA2 deacetylation at K302. This modification weakens ANXA2‑mTOR binding and releases autophagic‑flux suppression in nucleus pulposus cells. Dysregulated Zn2+ homeostasis disrupts this axis to drive intervertebral disc degeneration.
Yuxin Jin +23 more
wiley +1 more source
Irritability and Hormone Replacement Therapy in Women Attending a Menopause Clinic: A Cross-Sectional Study. [PDF]
Olivola M +12 more
europepmc +1 more source
Hormone replacement therapy and gynecological cancer.
The aim of this paper is to report the risk of development of gynecological cancer in women receiving hormone replacement therapy and to review the current knowledge on the administration of hormone replacement therapy following treatment of ...
Cosio S +3 more
core
We integrated RNA‐seq data from humans, pigs, and mice across 15 matched tissues based on 14 910 one‐to‐one orthologous genes. Cross‐species similarity was systematically evaluated across multiple regulatory layers, including global co‐expression conservation, co‐expression networks, tissue‐specific programs, and 3D genome architecture.
Jingwen Dou +21 more
wiley +1 more source
Hormone Replacement Therapy after Prophylactic Adnexectomy
This Pascale +5 more
doaj +1 more source
Partnership as a modulator of the effects of hormone replacement therapy in menopause. [PDF]
Fiala L, Lenz J.
europepmc +1 more source
SPRED2 Negatively Regulates CD8+ T Cell‐Mediated Antitumor Immunity in Breast Cancer
Sprouty‑related EVH1 domain containing 2 (SPRED2) restrains Ras/Raf/ERK signaling in CD8+ T cells. Host SPRED2 deficiency enhances T‐cell survival, cytotoxicity, and memory‐like phenotypes, reducing primary tumor growth and endpoint lung metastatic burden in breast cancer models.
Miao Tian +8 more
wiley +1 more source
Hormone replacement therapy and asthma in women: untangling a complex relationship. [PDF]
Wang JG.
europepmc +1 more source
Cyclin‐dependent kinase (CDK) 1 activity is a dynamic marker of treatment response in estrogen receptor positive breast cancer. Patient cohorts reveal CDK1 activity increases during progression to invasive disease, where high expression correlates with poor survival. Using a novel Cdk1 biosensor mouse alongside in vitro models, we demonstrate that CDK1
Sarah Alexandrou +17 more
wiley +1 more source
Menopause and Alzheimer's disease: can hormone replacement therapy modify the risk? A narrative review. [PDF]
Wang JY, Ansorge O.
europepmc +1 more source

